Cancer Therapy Advisor » Lymphoma News
33 FOLLOWERS
Non-Hodgkins and Hodgkins lymphoma news, research and treatment studies, latest cancer articles, clinical trials and more for oncologists, and medical professionals. Also includes latest news about mantle cell lymphoma and other forms of lymphoma. Cancer Therapy Advisor offers oncology healthcare professionals news and updates, as well as a comprehensive knowledge base of oncology information.
Cancer Therapy Advisor » Lymphoma News
4M ago
The prescribing information for Yescarta (axicabtagene ciloleucel) has been updated to include overall survival data in adults with relapsed or refractory LBCL ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
The prescribing information for Brukinsa (zanubrutinib) has been updated to include PFS data in patients with relapsed or refractory CLL/SLL ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Acalabrutinib and rituximab given before and after chemoimmunotherapy and transplant appears safe and active in patients with MCL ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
MRD-guided therapy can improve outcomes in patients with previously untreated CLL, phase 3 data suggest ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
First-line treatment with LTRA followed by CHOP produced a 100% complete response rate in DLBCL patients who completed both regimens ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Treatment with bleomycin is associated with long-term lung dysfunction in patients with classical Hodgkin lymphoma, data suggest ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Studies presented at ASH 2023 provided new insights and updates that may inform the treatment of lymphomas ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Golidocitinib can produce lasting responses in patients with relapsed or refractory PTCL, according to a new study ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Jylamvo, an oral solution formulation of methotrexate, is now available from Shorla Oncology and Eversana ..read more
Cancer Therapy Advisor » Lymphoma News
4M ago
Revumenib has demonstrated activity in patients with relapsed or refractory acute leukemia harboring a ..read more